Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / CA - Medicenna Therapeutics granted 180-day extension to meet Nasdaq complaince

CA - Medicenna Therapeutics granted 180-day extension to meet Nasdaq complaince

CA Inc.

2023-04-27 07:59:01 ET

  • Clinical stage immuno-oncology company, Medicenna Therapeutics ( NASDAQ: MDNA ) received a notice from the Nasdaq granting the request for a 180-day extension to regain compliance with the minimum bid price requirement of $1 per share.
  • The company was first notified by Nasdaq of its failure to comply with the minimum bid requirement on October 25, 2022, and was given until April 24, 2023 to regain compliance.
  • The company now has until October 23, 2023 to meet the requirement.

For further details see:

Medicenna Therapeutics granted 180-day extension to meet Nasdaq complaince
Stock Information
Company Name: CA Inc.
Stock Symbol: CA
Market: NASDAQ
Menu
CA CA Quote CA Short CA News CA Articles CA Message Board
Get CA Alerts

News, Short Squeeze, Breakout and More Instantly...